MedPath

GenSci120

Generic Name
GenSci120

A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.

Phase 1
Recruiting
Conditions
Autoimmune Disease
Interventions
Drug: Placebo
First Posted Date
2025-02-14
Last Posted Date
2025-02-25
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
56
Registration Number
NCT06827457
Locations
🇨🇳

Huashan Hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath